Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

New clues into why people with type 2 diabetes develop dementia

by Kate Wighton,Imperial College LondonCredit: CC0 Public DomainNew research may help explain why people with type 2 diabetes are more likely to develop dementia.The findings, from scientists at

Updated on: March 13,2024

New clues into why people with type 2 diabetes develop dementia

by Kate Wighton,Imperial College LondonCredit: CC0 Public DomainNew research may help explain why people with type 2 diabetes are more likely to develop dementia.The findings, from scientists at

Updated on:March 13,2024

Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on: May 13,2024

Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on:May 13,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on: October 16,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on:October 16,2024

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on: March 28,2024

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on:March 28,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on: December 17,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on:December 17,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on: March 07,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on:March 07,2024

Socioeconomic deprivation linked to higher risk of epilepsy related to traumatic brain injury

by Lori SolomonSocioeconomic deprivation increases the risk for sustaining a traumatic brain injury (TBI), and in some age groups, it may also increase the risk for epilepsy after a TBI, according to

Updated on: July 17,2024

Socioeconomic deprivation linked to higher risk of epilepsy related to traumatic brain injury

by Lori SolomonSocioeconomic deprivation increases the risk for sustaining a traumatic brain injury (TBI), and in some age groups, it may also increase the risk for epilepsy after a TBI, according to

Updated on:July 17,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on: February 26,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on:February 26,2024

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th

Updated on: April 01,2024

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th

Updated on:April 01,2024

Interactive app to assist rehabilitation of Alzheimer's patients

by Asociacion RUVIDTesting the Alzheimer's app prototype in the communityResearchers from the Polytechnic University of Valencia take their new Alzheimer's app out for first testing and f

Updated on: February 27,2024

Interactive app to assist rehabilitation of Alzheimer's patients

by Asociacion RUVIDTesting the Alzheimer's app prototype in the communityResearchers from the Polytechnic University of Valencia take their new Alzheimer's app out for first testing and f

Updated on:February 27,2024